Dr. Thomas Ecker
Ecker + Ecker GmbH, Hamburg
CEO;
Thomas Ecker is CEO of Ecker + Ecker. Since 2004 he has focused on HTA, Pricing and Reimbursement of pharmaceuticals. In that role he has been responsible for more than 100 G-BA submissions and price negotiations. His current focus is on EU HTA strategy and dossier development.
More information please click here.
Alain Estival
Cemka, France
Co-Director Market Access
Christian Hill
MAP Patient Access, Cambridge, GREAT BRITAIN
Chief Executive Officer Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications. Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.
Luis Lizán
Outcomes 10, Spain
CEO
Mariangela Prada
Intexo Società Benefit Srl, Italy
CEO & Partner
13/12/2023
13/12/2023
09:00 am - 1:00 pm; You may dial in ...
09:00 am - 1:00 pm; You may dial in 30 min in advance
online
online
Veranstaltung - 850 € zzgl. MwSt.
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
Veranstaltung - 850 € zzgl. MwSt.
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
Dr. Henriette Wolf-Klein
Head of Department
+49 6221 500-680
h.wolf-klein@forum-institut.de
This webcast covers HTA procedures and alignment with the EU-HTA processes in France, Italy, Spain and UK
This webcast focuses on the national preparation for the EU HTA in France, Italy and Spain, and the influence of the EU HTA on UK HTA processes. Four national experts will provide the latest information on national procedures in the transition period as well as country-specific preparations for the EU HTA.
09:00
Dr Thomas Ecker
09:30
Christian Hill
10:20 Coffee break
10:30
Alain Estival
11:20
Mariangela Prada
12:10 Coffee break
12:20
Luis Lizán
13:00 End of the webcast
Overall score of all evaluations in 2022
Five stars on Trustpilot = Excellent
In diesem Seminar erfahren Sie alle Prozessschritte vom ersten Beratungsgespräch über die G-BA Entscheidung bis zum etwa...
Erwerben Sie in diesem e-Learning Einsteigerwissen für MSL - von Aufgaben über Zielgruppen bis hin zu juristischen Basic...
Ein Seminar über die verantwortlichen Personen von pharmazeutischen Unternehmen und des Großhandels - die Aufgaben, Vera...
Seminar zur Preisbildung, Abrechnung und Erstattung von Arzneimitteln in Deutschland
Mit unserem speziell auf Medizinprodukteberater zugeschnittenen Refresher e-Learning erhalten Sie Ihr Update - damit Sie...